Drug discovery for hyperuricemia.
1Kyorin University School of Medicine, Department of Pharmacology and Toxicology, 6-20-2, Shinkawa, Mitaka-shi, Tokyo 181-8611, Japan +81 422 47 5511 (ext 3692) ; +81 422 79 1321 ; anzai@kyorin-u.ac.jp.
Hyperuricemia increases gout risk, but new therapies targeting renal urate transport, like URAT1, offer improved gout and kidney stone management.
Area of Science:
- Nephrology
- Pharmacology
- Biochemistry
Background:
- Hyperuricemia is a key risk factor for gout, with risk escalating with severity and duration.
- Gout management involves diet and urate-lowering drugs.
- Understanding urate transport mechanisms is crucial for developing effective gout treatments.
Purpose of the Study:
- To review the role of renal urate transporters, particularly URAT1 (SLC22A12), in gout pathophysiology.
- To explore the potential of targeting URAT1 for novel gout and hyperuricemia therapeutics.
- To highlight the significance of the urate transportsome in drug development.
Main Methods:
- Literature review of studies on hyperuricemia, gout, and renal urate transport.
- Analysis of the function and regulation of URAT1 and related membrane proteins.
- Examination of existing and potential pharmacologic interventions targeting urate transport.
Main Results:
- URAT1 and other membrane proteins are central to renal urate reabsorption.
- The mode of action of several gout medications involves modulation of urate transport.
- Targeting URAT1 presents a promising strategy for managing hyperuricemia-related conditions.
Conclusions:
- Therapeutics modifying URAT1 activity could effectively treat gout and urolithiasis.
- Further research into the urate transportsome will drive the development of advanced hyperuricemia therapies.
- Understanding urate transport is key to advancing treatment for metabolic disorders.
Related Concept Videos
Drug Discovery: Overview
Pharmacogenomics: Identification of New Drug Targets
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Urinary Tract Calculi III: Medical Management
Antihypertensive Drugs: Action of Diuretics
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
![Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F61682.jpg&w=3840&q=50)
